Plasma protein profiling of Mild Cognitive Impairment and Alzheimer’s disease using iTRAQ quantitative proteomics

BACKGROUND: With the promise of disease modifying treatments, there is a need for more specific diagnosis and prognosis of Alzheimer’s disease (AD) and mild cognitive impairment (MCI). Plasma biomarkers are likely to be utilised to increase diagnostic accuracy and specificity of AD and cognitive dec...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Song, Fei, Poljak, Anne, Kochan, Nicole A, Raftery, Mark, Brodaty, Henry, Smythe, George A, Sachdev, Perminder S
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2014
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3898732/
https://ncbi.nlm.nih.gov/pubmed/24433274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-5956-12-5
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares